Lymphopenia Tied to Risk of Infection After Radiotherapy
Measuring lymphocytes during or after radiotherapy could provide useful information about infection risk, according to researchers.
Measuring lymphocytes during or after radiotherapy could provide useful information about infection risk, according to researchers.
Patients who had sarcopenia and an elevated neutrophil-to-lymphocyte ratio had the worst overall survival.
Patients who had high baseline troponin T levels had a more than 3-fold greater risk of MACE.
Researchers assessed pain and HRQOL measures with olaparib vs physician’s choice of treatment in patients with prostate cancer.
The 5-year metastasis-free survival was similar with trimodal therapy and radical cystectomy.
New findings could inform personalized therapeutic strategies for patients with renal cell carcinoma, according to investigators.
The median progression-free survival was similar between the treatment arms.
The study’s primary endpoint was met, and neoadjuvant chemotherapy was considered well tolerated.
Bone loss was observed in both treatment arms, but abiraterone plus prednisone did not increase bone loss.
An AI tool outperformed NCCN guidelines for predicting biochemical failure, distant metastasis, prostate cancer-specific survival, and overall survival.